Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 240,000 shares at $1.34 ($325K) on 2024-02-08, disclosed to the SEC on 2024-02-09.
Open-market purchase of $325k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.38 | 36,374 | $50K | 15.5% |
| 2 | $1.38 | 36,374 | $50K | 15.5% |
| 3 | $1.34 | 83,626 | $112K | 34.5% |
| 4 | $1.34 | 83,626 | $112K | 34.5% |
| Total | $1.35 avg | 240,000 | $325K | 100% |
| Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |
| BRTX | BUY | 2023-09-18 | $32K | — | Filing → |